Event

Reducing Diagnostic Complexity with New Biomarkers
August 17, 2018 - August 20, 2018

Friday, August 17th, 2018

12:00PM-1:30PM

JW Marriott Scottsdale Camelback Inn Resort & Spa

5402 E. Lincoln Dr.
Scottsdale , AZ 85253 , United States
Schedule

New markers hold great potential to improve care of Autoimmune diseases. We will: 

  • Introduce a novel particle-based multi-analyte technology (PMAT) 
  • Identify the contribution of novel biomarkers in the differential diagnostics of autoimmune diseases
  • Hear from a clinical perspective how multi-analyte detection of autoantibodies can help close the seronegative gap and improve clinical assessment

TO REGISTER:
Contact Maggie Fogle at AMLI: maggie@maggiefogle.com

Please contact your Inova Diagnostics sales representative or visit www.amli.org and www.inovadx.com for more information.

Multi-analyte detection of autoantibodies improves clinical assessment

Carlos A. von Mühlen MD, PhD
Carlos A. von Mühlen MD, PhD

Dr. von Mühlen has a Medical and Master’s degree in Clinical Medicine from Universidade Federal do Rio Grande do Sul, Brazil, and earned his PhD at the Rheinisch-Westfalische Technische Hochschule/Aachen School of Medicine, Germany. He also served as a Post-Doctoral Fellow in Autoimmune Diseases at the Scripps Research Institute under Eng M. Tan, MD.

Contact us


Please contact us directly via email, telephone, or with the following form.

EMAIL:

support@inovadx.com

TOLL FREE PHONE:

800.545.9495

PHONE:

858.586.9900

FAX:

858.586.9911